CNSDOSE
The CNSDose Report - powered by DNA - guides which antidepressant and dose is most appropriate. With world-first understanding of how antidepressants reach the brain, and backed by clinical trial evidence, CNSDose is the first 2nd generation pharmacogenetic report.
CNSDOSE
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2015-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.cnsdose.com
Total Employee:
1+
Status:
Active
Contact:
+61352487211
Email Addresses:
[email protected]
Total Funding:
1000 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network
Similar Organizations
Corscans
CorScans is a healthcare organization that operates a healthcare platform that bridges the gap between doctors and their patients.
MediQuo
Spainโs 24-hour, 7-day-a-week medical chat application.
Neoclinical
Neoclinical matches clinical trials with the patients that need them the most.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Current Employees Featured
Founder
Investors List
Melbourne Accelerator Program
Melbourne Accelerator Program investment in Seed Round - CNSDose
Newest Events participated
Official Site Inspections
http://www.cnsdose.com Semrush global rank: 6.75 M Semrush visits lastest month: 820
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "CNSDose"
CNSDose - Crunchbase Company Profile & Funding
Organization. CNSDose . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. CNSDose provides gene testing service and โฆSee details»
CNSDose Company Profile | Management and Employees List
CNSDose Profile and History The CNSDose Report - powered by DNA - guides which antidepressant and dose is most appropriate. With world-first understanding of how โฆSee details»
CNSDose - Fast-Track Finding the Right Medications for You
CNSDose is provided by Incite Genomics, an Australian healthcare company providing genetic testing and clinical support tools. We are dedicated to improving lives through personalised โฆSee details»
CNSDose - Company Profile - Tracxn
Nov 27, 2024 CNSDose - Developer of pharmacogenomics tools for treatment regimens using anti-depressants. Acquired by Incite Health. Raised a total funding of $1.01M over 2 rounds โฆSee details»
CNSDose Company Profile 2024: Valuation, Investors, Acquisition
CNSDose General Information Description. Developer of antidepressant prescription software designed to find suitable antidepressant medicines. The company's platform develops a โฆSee details»
CNSDose - Products, Competitors, Financials, Employees, โฆ
CNSDose develops antidepressant prescription software. It is designed to find suitable antidepressant medicines. Its platform develops a genomic test to predict psychiatric drug โฆSee details»
CNSDose: Contact Details and Business Profile - RocketReach
CNSDose - our US$140 cutting edge RCT evidence backed blood-brain-barrier pharmacogenetic powered report boosts antidepressant remission rates. Start a conversation with your doctor...See details»
CNSDose Company Profile - Office Locations, Competitors ... - Craft
CNSDose is a personalized medicine company focused on genetic tests helping to find medications for mental health disorders. It offers an Amplis software that delivers medication โฆSee details»
CNSDose Pty Ltd.: Drug pipelines, Patents, Clinical trials - Synapse
Jun 27, 2023 Explore CNSDose Pty Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
CNSDose - LinkedIn
CNSDose - our US$140 cutting edge RCT evidence backed blood-brain-barrier pharmacogenetic powered report boosts antidepressant remission rates. CNSDose | 402 followers on LinkedIn.See details»
CNSDose
Powered by Australia's leading university, the Melbourne Accelerator Program (MAP) was launched in 2012 as one of the first startup accelerators in Australia. Every year we invest in โฆSee details»
CNS Dose | World Economic Forum
The World Economic Forum is an independent international organization committed to improving the state of the world by engaging business, political, academic and other leaders of society to โฆSee details»
CNSDose - Contacts, Employees, Board Members, Advisors & Alumni
Organization. CNSDose . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. CNSDose has 3 โฆSee details»
CNSDose Company Profile: Funding, Investors & Partnerships
CNSDose is a pharmacogenetics company focusing on mental health and central nervous system disorders. CNSDose uses a cloud-platform to interface with pathology lab IT systems, and โฆSee details»
CNSDose - Overview, News & Similar companies | ZoomInfo.com
CNSDose contact info: Phone number: +61 352487211 Website: www.cnsdose.com What does CNSDose do? The CNSDose Report - powered by DNA - guides which antidepressant and โฆSee details»
CNSDose - Fast-Track Finding the Right Medications for You
CNSDose was developed in response to the need of clinicians specialising in Psychiatry and general practice. The blood-brain barrier is a filtering system of the small blood vessels that โฆSee details»
CNSDose - Startup Galaxy
The CNSDose Report - powered by DNA - guides which antidepressant and dose is most appropriate. With world-first understanding of how antidepressants reach the brain, and โฆSee details»
CNSDose® - Simple and Practical Mental Health
CNSDose® is a proprietary, commercially-available battery of pharmacogenomic tests (CNSDose, LLC). The test battery includes evaluation of genetic variations in the genes coding for: 1. โฆSee details»
CNSDose โ Mental Health - incite genomics
CNSDose provides a specific focus on medications used in the treatment of various mental health illnesses, including antidepressants, anxiolytics, anti-ADHD and antipsychotics. The CNSDose โฆSee details»
Engagement around supervised consumption site will be ongoing, โฆ
1 day ago The organization that will lead the provinceโs first supervised consumption site says more consultation is to come. The Manitoba government and the Aboriginal Health and โฆSee details»